Is a thicket of patents strangling a nascent industry?
Dean Baker says it’s time to start talking seriously about the way in which pharma is funded
Suffering stagnant output, and beset by patent expiries and spiralling costs, drug discovery is in poor health. Simon Campbell prescribes a remedy
Sean Seymore’s career has taken him from the lab to law school and back again. Yfke Hager determines his motive
Row over ultimate control of the planned European single patent court brings the process to a juddering halt once more
The struggle for a single unitary European patent may be close to an end, says Darren Smyth, but we must still hold out for an agreement that performs as it should
© Royal Society of Chemistry Registered charity number: 207890
Site powered by Webvision Cloud